Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MMS stock price vs CTAS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTAS's multiple
Needs CTAS P/E.
Implied fair value · at MMS's multiple
Needs MMS P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Maximus, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Cintas Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Accenture plc
MMS vs ACN
INTERNATIONAL BUSINESS MACHINES CORP
MMS vs IBM
CACI INTERNATIONAL INC /DE/
MMS vs CACI
ROLLINS INC
MMS vs ROL
IRON MOUNTAIN INC
MMS vs IRM
UNIFIRST CORP
MMS vs UNF
ABM INDUSTRIES INC /DE/
MMS vs ABM
Aramark
MMS vs ARMK
W.W. GRAINGER, INC.
MMS vs GWW
INTUIT INC.
MMS vs INTU
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MMS can sustain its current profitability and gradually improve growth without taking on much more leverage, then MMS looks attractive versus CTAS on relative valuation because it trades at a fraction of CTAS’s P/E, EV/EBITDA, and EV/Revenue multiples.
MMS trades at a steep discount to CTAS on earnings, sales, and EBITDA multiples, which explains most of the apparent upside in CTAS-based valuation. The market is effectively paying a much lower multiple for MMS despite reasonable quality metrics and a valuation range that sits close to the current price.
Supporting Metrics
